Plexus Corp. (PLXS) – What Are Brokerages Saying About This Stock?

Shares of Plexus Corp. (NASDAQ:PLXS – Get Free Report) have received an average rating of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $276.86.

PLXS has been the topic of several analyst reports. KeyCorp raised shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price target on the stock in a report on Monday, September 21st. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Needham & Company LLC reissued a “buy” rating and issued a $310.00 price objective on shares of Plexus in a research report on Friday, August 14th. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a research note on Friday, July 31st. Finally, Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a research note on Sunday, October 4th.

Get Our Latest Stock Analysis on Plexus

Plexus Stock Performance

Shares of Plexus stock opened at $220.78 on Friday. The company has a market capitalization of $5.91 billion, a PE ratio of 35.21 and a beta of 0.88. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49. The company has a 50-day simple moving average of $250.63 and a two-hundred day simple moving average of $258.62. Plexus has a one year low of $132.03 and a one year high of $307.06.

Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 EPS for the quarter, beating the consensus estimate of $2.13 by $0.19. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same period in the prior year, the firm posted $1.64 earnings per share. The company’s quarterly revenue was up 28.2% on a year-over-year basis. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Research analysts expect that Plexus will post 7.13 EPS for the current fiscal year.

Insider Buying and Selling at Plexus

In other Plexus news, Director Michael V. Schrock sold 4,000 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total value of $1,100,000.00. Following the completion of the sale, the director owned 40,329 shares of the company’s stock, valued at approximately $11,090,475. This trade represents a 9.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the completion of the sale, the director directly owned 7,535 shares of the company’s stock, valued at approximately $1,814,955.45. This represents a 6.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 9,000 shares of company stock worth $2,319,260. 1.78% of the stock is owned by insiders.

Institutional Trading of Plexus

Institutional investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in Plexus during the 2nd quarter valued at approximately $1,311,631,000. Congress Asset Management Co. raised its holdings in shares of Plexus by 204.0% in the third quarter. Congress Asset Management Co. now owns 315,396 shares of the technology company’s stock worth $82,303,000 after buying an additional 211,663 shares during the last quarter. Bank of America Corp DE acquired a new stake in shares of Plexus during the second quarter worth $60,281,000. Bank of New York Mellon Corp acquired a new stake in shares of Plexus during the second quarter worth $55,525,000. Finally, Emerald Advisers LLC acquired a new stake in shares of Plexus during the first quarter worth $33,729,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Plexus Company Profile

(Get Free Report)

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

Further Reading

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.